Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00096044 Information provided by Roswell Park Cancer Institute

First Received: November 9, 2004 Last Updated: October 3, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)